Skip to content

A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement

A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02875730
Acronym
LAMDE
Enrollment
10
Registered
2016-08-23
Start date
2016-12-13
Completion date
2018-04-27
Last updated
2018-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Cryoablation

Brief summary

This is a prospective trial investigating the effectiveness of a modified MRI preparatory pulse sequence to improve pulmonary vein isolation visualization.

Interventions

PROCEDUREPulse Sequence

Cylindrical Navigator Preparatory Pulse Sequence

PROCEDURECMRI

Cardiac Magnetic Resonance Imaging

Sponsors

Aspire Foundation
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Men or non-pregnant women * A diagnosis of symptomatic paroxysmal or recently persistent atrial fibrillation with a documented successful cardioversion within 4 months of the procedure * Documented treatment failure or intolerance of at least 1 anti-arrhythmic medication used to control atrial fibrillation.

Exclusion criteria

* Contraindication to MRI, such as implanted incompatible metal prosthesis, or subject size exceeds bore or table limits * Allergy to gadolinium-based contrast agent * Previous atrial fibrillation ablation * Renal dysfunction (estimated GFR \<60 mL/min/1.73m2) within 6 months * Unwilling to provide informed consent for this protocol

Design outcomes

Primary

MeasureTime frame
Blood Pool Corrected Signal IntensityThrough study completion, an average of 1 year
Imaging Failure RateThrough study completion, an average of 1 year
Extent of Detected LGE Signal Correlate to the Respiratory Navigator SchemeThrough study completion, an average of 1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026